Home›Search›Molecular Diagnosis and Therapy

Molecular Diagnosis and Therapy

ADIS INT LTD · Switzerland · Est. 1992

ISSN1179-2000

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.812

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

1.09

Total Worksi

1,136

Total Citationsi

25,266

2yr Mean Citednessi

5.07

Open Impact Factor alternative

Aims & Scope

Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine. Via a program of reviews and original research articles, the journal is focused on linking diagnostic and prognostic biomarkers to appropriate therapy, with an emphasis on the development of companion diagnostic/therapeutic products, along with the analysis of pharmacogenomic data for drug development and therapeutic decision making.

General Information

Country / RegionSwitzerland

Primary LanguageEnglish

1st Year Published1992

FrequencySix No. A Year

StatusActive (last: 2026)

Total Publications1,136

Publisher OrgAdis, Springer Healthcare

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

ADIS INT LTD

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1179-2000

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1.9k

2019

1.6k

2020

1.7k

2021

1.1k

2022

944

2023

726

2024

241

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

GeneticsQ1

Medicine (miscellaneous)Q1

Molecular MedicineQ1

PharmacologyQ1

Subject Classification

Web of Science Categories

Genetics & HeredityPharmacology & Pharmacy

Scopus Categories

Molecular MedicinePharmacologyGeneticsMedicine (miscellaneous)

Research Topics (OpenAlex)

Cancer Genomics and DiagnosticsMicroRNA in disease regulationLung Cancer Treatments and MutationsPharmacogenetics and Drug MetabolismGenomics and Rare DiseasesMolecular Biology Techniques and ApplicationsColorectal Cancer Treatments and StudiesCircular RNAs in diseasesCRISPR and Genetic EngineeringGenetic factors in colorectal cancer

Frequently asked questions about Molecular Diagnosis and Therapy

Is Molecular Diagnosis and Therapy a predatory journal?

PubScope has no integrity flags on record for Molecular Diagnosis and Therapy: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Molecular Diagnosis and Therapy?

Molecular Diagnosis and Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 5.07.

Is Molecular Diagnosis and Therapy indexed in Scopus and Web of Science?

Molecular Diagnosis and Therapy is indexed in Web of Science, Scopus.